These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8872795

  • 41. Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
    Brunner M, Cooper-DeHoff RM, Gong Y, Karnes JH, Langaee TY, Pepine CJ, Johnson JA, INVEST Investigators.
    Am J Cardiol; 2007 Jun 01; 99(11):1549-54. PubMed ID: 17531579
    [Abstract] [Full Text] [Related]

  • 42. Efficacy and tolerability of trandolapril in mild to moderate hypertension--a double blind comparative clinical trial with enalapril in Indian population.
    Shankar PK, Vidyasagar S, Adiga S, Naidu MU, Usha Rani P, Rao D, Bairy KL, Nair S, Jayaprakash B, Shashikiran U, Mukhyapranaprabhu.
    Indian J Physiol Pharmacol; 2006 Jun 01; 50(4):421-6. PubMed ID: 17402274
    [Abstract] [Full Text] [Related]

  • 43. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW.
    Clin Ther; 2009 Sep 01; 31(9):1946-56. PubMed ID: 19843484
    [Abstract] [Full Text] [Related]

  • 44. [A Brazilian multicenter study to evaluate the clinical effectiveness and tolerance of isradipine SRO using ambulatory monitoring of arterial pressure in the treatment of mild and moderate arterial hypertension].
    Magliano MF, Amodeo C, Mion Júnior D, Francischetti E, Lima Júnior E, Nobre F, Chaves H, Ribeiro JM, Spritzer N, Jardim PC.
    Arq Bras Cardiol; 1993 Nov 01; 61(5):311-8. PubMed ID: 8147731
    [Abstract] [Full Text] [Related]

  • 45. Differential effects of a missed dose of trandolapril and enalapril on blood pressure control in hypertensive patients.
    Vaur L, Dutrey-Dupagne C, Boussac J, Genes N, Bouvier d'Yvoire M, Elkik F, Meredith PA.
    J Cardiovasc Pharmacol; 1995 Jul 01; 26(1):127-31. PubMed ID: 7564352
    [Abstract] [Full Text] [Related]

  • 46. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
    Oigman W, Gomes MA, Pereira-Barretto AC, Póvoa R, Kohlmann O, Rocha JC, Nobre F.
    Clin Ther; 2013 May 01; 35(5):702-10. PubMed ID: 23623755
    [Abstract] [Full Text] [Related]

  • 47. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O, Laroche P, Vidal JS, Pannier B, Postel-Vinay N, Vaisse B, Girerd X.
    Ann Cardiol Angeiol (Paris); 2012 Jun 01; 61(3):218-23. PubMed ID: 22695025
    [Abstract] [Full Text] [Related]

  • 48. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
    Mallion JM, Omboni S, Barton J, Van Mieghem W, Narkiewicz K, Panzer PK, Puig JG, Stefanadis C, Zweiker R, Study Group.
    Blood Press Suppl; 2011 Apr 01; 1():3-11. PubMed ID: 21091270
    [Abstract] [Full Text] [Related]

  • 49. Self-measured home blood pressure in predicting ambulatory hypertension.
    Mansoor GA, White WB.
    Am J Hypertens; 2004 Nov 01; 17(11 Pt 1):1017-22. PubMed ID: 15533727
    [Abstract] [Full Text] [Related]

  • 50. Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension.
    Smolensky MH, Hermida RC, Portaluppi F.
    Chronobiol Int; 2007 Nov 01; 24(1):171-81. PubMed ID: 17364587
    [Abstract] [Full Text] [Related]

  • 51. Ambulatory blood pressure and urinary albumin excretion in diabetic (non-insulin-dependent and insulin-dependent) hypertensive patients: relationships at baseline and after treatment by the angiotensin converting enzyme inhibitor trandolapril.
    Bauduceau B, Genès N, Chamontin B, Vaur L, Renault M, Etienne S, Marre M.
    Am J Hypertens; 1998 Sep 01; 11(9):1065-73. PubMed ID: 9752891
    [Abstract] [Full Text] [Related]

  • 52. Early morning home blood pressure control among treated patients with controlled office blood pressure.
    Zuo HJ, Song XT, Yang HX, Deng LQ, Wang JW.
    J Clin Hypertens (Greenwich); 2019 Dec 01; 21(12):1823-1830. PubMed ID: 31769172
    [Abstract] [Full Text] [Related]

  • 53. Permanent blood pressure control over the 24 h by trandolapril.
    Omboni S, Ravogli A, Villani A, Mancia G.
    Am J Hypertens; 1995 Oct 01; 8(10 Pt 2):71S-74S. PubMed ID: 8845088
    [Abstract] [Full Text] [Related]

  • 54. Once-daily trandolapril compared with the twice-daily formulation in the treatment of mild to moderate essential hypertension: assessment by conventional and ambulatory blood pressures.
    Poirier L, Bourgeois J, Lacourcière Y.
    J Clin Pharmacol; 1993 Sep 01; 33(9):832-6. PubMed ID: 8227480
    [Abstract] [Full Text] [Related]

  • 55. Electronic pill-boxes in the evaluation of antihypertensive treatment compliance: comparison of once daily versus twice daily regimen.
    Andrejak M, Genes N, Vaur L, Poncelet P, Clerson P, Carré A.
    Am J Hypertens; 2000 Feb 01; 13(2):184-90. PubMed ID: 10701819
    [Abstract] [Full Text] [Related]

  • 56. Effect of antihypertensive treatment on office and self-measured blood pressure: the Autodil study.
    Leeman MJ, Lins RL, Sternon JE, Huberlant BC, Fassotte CE.
    J Hum Hypertens; 2000 Aug 01; 14(8):525-9. PubMed ID: 10962521
    [Abstract] [Full Text] [Related]

  • 57. The velocity of home blood pressure reduction in response to low-dose eplerenone combined with other antihypertensive drugs determined by exponential decay function analysis.
    Elnagar N, Satoh M, Hosaka M, Asayama K, Ishikura K, Obara T, Mano N, Ohkubo T, Imai Y.
    Clin Exp Hypertens; 2014 Aug 01; 36(2):83-91. PubMed ID: 24625334
    [Abstract] [Full Text] [Related]

  • 58. Acute blood pressure response to trandolapril and captopril in patients with left ventricular dysfunction after acute myocardial infarction.
    Weber S, Vaur L, Ounnoughene Z, Schwob J, Dubroca I, Normand J, Etienne S, Charbonnier B.
    Am Heart J; 2002 Feb 01; 143(2):313-8. PubMed ID: 11835037
    [Abstract] [Full Text] [Related]

  • 59. Time-effect profile of antihypertensive agents assessed with trough/peak ratio, smoothness index and dose omission: an ambulatory blood pressure monitoring study with trandolapril vs. quinapril.
    Radauceanu A, Virion JM, Boivin JM, Zannad F.
    Fundam Clin Pharmacol; 2002 Dec 01; 16(6):545-54. PubMed ID: 12685514
    [Abstract] [Full Text] [Related]

  • 60. Influence of self-measurement of blood pressure on the responder rate in hypertensive patients treated with losartan: results of the SVATCH Study. Standard vs Automatic Treatment Control of COSAAR in Hypertension.
    Vetter W, Hess L, Brignoli R.
    J Hum Hypertens; 2000 Apr 01; 14(4):235-41. PubMed ID: 10805048
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.